Allergy vaccination is a unique approach to allergy management as it treats the underlying cause of the allergy, provides sustained symptom prevention and has been shown to reduce the risk of developing asthma.
Allergy vaccination is a treatment based on controlled doses of purified and standardised allergens (proteins), extracted from natural allergen sources: Pollens (grass, trees etc.), house dust mites, animals, insect stings. During the treatment, the immune system is gradually desensitised, so that the patient gets accustomed to the allergens that normally cause an allergic reaction.
Allergy vaccination is a clinically documented efficacious treatment, which considerably reduces or completely removes the patient’s allergic symptoms and the need for traditional, symptom-relieving medication. Furthermore, the treatment has a longstanding effect after it is discontinued. An additional effect is that the natural aggravation of the allergic disease is inhibited and the development of asthma or new allergies may be prevented.
Tablet-based allergy vaccines
The development of more convenient ways to administer allergy vaccination has been driven by the need to provide patients with greater access to the benefits of the treatment.
Drop formulation of sublingual vaccines represented the first step in the development of more accessible treatments. The development of tablet-based allergy vaccines from ALK is a ground-breaking new treatment approach for allergic patients, which can form the foundation of their allergy therapy.